Colin Hislop, Chief Medical Officer at Anthera Pharmaceuticals Inc (ANTH), sold 15,000 shares at $6.74 ($101K) on 2011-11-08, disclosed to the SEC on 2011-11-10.
Open-market sale of $101k ANTH by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANTH | SELL | 2015-11-18 | $66K | — | Filing → |
| ANTH | SELL | 2015-11-12 | $27K | — | Filing → |
| ANTH | SELL | 2012-02-06 | $246K | — | Filing → |